_256_384.jpg)
News | November 02, 2025
Cipla posts consolidated Q2 FY26 PAT Rs. 1,351.17 Cr
Cipla has reported total income of Rs. 7,858.39 crore during the period ended September 30, 2025
Cipla has reported total income of Rs. 7,858.39 crore during the period ended September 30, 2025
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
Tatva Chintan Pharma Chem has reported total income of Rs. 124.52 crore during the period ended September 30, 2025
Indraprastha Medical Corporation has reported total income of Rs. 388.40 crore during the period ended September 30, 2025
Medplus Health Services has reported total income of Rs. 1,696.79 crore during the period ended September 30, 2025
With over two decades of extensive experience, Lal has established himself as a transformational leader in the FMCG and consumer goods sectors
Performance driven by growth portfolio momentum, pipeline advancements, and strategic business development
Dr. Jindal reflects on bridging accessibility gaps between urban and rural regions, the ethical and emotional aspects of family building, and how initiatives like adoption facilitation centers align with his lifelong mission to help couples realize the dream of parenthood
The FDA’s review also revealed delays in Philips’ internal investigations, with 54 inquiries failing to meet targeted completion dates—23 of which were delayed by more than 100 days
Cobenfy generated $43 million in third-quarter sales, up from $35 million in the second quarter
Subscribe To Our Newsletter & Stay Updated
